周二，Truist Securities调整了Inspire Medical Systems (NYSE: INSP )的股票目标价，从250.00美元下调至235.00美元，同时维持买入评级。此次调整是在公司第四季度每股收益 ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...

Key Insights The projected fair value for Inspire Medical Systems is US$209 based on 2 Stage Free Cash Flow to ...

Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

KeyBanc Capital Markets将Inspire Medical的目标价从$236下调至$234，同时维持超配评级。这是在公司预先公布第四季度业绩和2025年初步指引之后作出的。公司预计2025年销售额在$940百万至$955百万之间。 Stifel分析师将Inspire Medical的目标价从$200下调至$190，维持持有评级。他们将调整归因于股价表现波动和对未来收入增长的担忧 ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Inspire Medical Systems (INSP – Research Report), ...

MINNEAPOLIS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, ...

Shares of NYSE INSP opened at $188.77 on Friday. The company has a 50 day moving average of $189.32 and a 200 day moving average of $186.43. Inspire Medical Systems has a twelve month low of $123. ...

Nisa Investment Advisors LLC lifted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 37.3% during the fourth quarter, Holdings Channel reports. The firm owned 368 ...

Inspire Medical Systems (NYSE:INSP) reported Q2 EPS of ($0.53), $0.08 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $91.4 million versus the... Leerink Partners ...